Spruce Biosciences, Inc. SEC filings SPRB
Spruce Biosciences, Inc. has 366 filings in SEC EDGAR's recent list, going back to Feb 28, 2020. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 26, 2025 | — |
| EFFECT | Filing | Nov 26, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| D | Filing | Oct 17, 2025 | — |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Apr 7, 2023 | — |
| CORRESP | Letter to the SEC | Apr 5, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2023 | — |
| D | Filing | Feb 28, 2023 | — |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 9, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2022 | — |
| EFFECT | Filing | Oct 8, 2020 | — |
| CORRESP | Letter to the SEC | Oct 6, 2020 | — |
| CORRESP | Letter to the SEC | Oct 6, 2020 | — |
| CERT | Filing | Oct 6, 2020 | — |
| 8-A12B | Filing | Oct 5, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 2, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 17, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2020 | — |
| D/A | Filing | Aug 14, 2020 | — |
| DRS | Filing | Aug 7, 2020 | — |
| D | Filing | Feb 28, 2020 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1683553
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.